Ratings Nolato AB London S.E.

Equities

0OA9

SE0015962477

Market Closed - London S.E. Other stock markets 09:07:50 29/09/2023 pm IST			5-day change	1st Jan Change
44.82 ^SEK	-18.66%		-27.65%	-15.67%

06/05	Nordic Stocks Moved Upward Monday; Nolato Series B Led Increases	DJ
06/05	Nolato AB Elects Klas Forsström as Ordinary Board Member	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For several months, analysts have been revising their EPS estimates roughly upwards.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The firm trades with high earnings multiples: 23.95 times its 2024 earnings per share.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
NOLATO AB	-15.67%	158.93Cr		-
BOROUGE PLC	-4.05%	1.94TCr		-
HEXPOL AB	+5.08%	419.18Cr		B
ELKEM ASA	+2.84%	131.22Cr		B-
ALLIED SUPREME CORP.	+19.82%	96Cr		-
SHANDONG DAWN POLYMER CO.,LTD.	-11.55%	69Cr	-	-
JENKEM TECHNOLOGY CO., LTD.	-36.36%	57Cr		-
JIANGSU MAYSTA CHEMICAL CO., LTD.	-13.97%	29Cr	-	-
DAQING HUAKE COMPANY LIMITED	-12.92%	25Cr	-	-
BGF CO., LTD.	-6.30%	25Cr		D-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes